{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:08:08Z","timestamp":1787760488904,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jacep.2026.01.052","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:45:08Z","timestamp":1773261908000},"page":"1648-1659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0971","authenticated-orcid":false,"given":"Konstantinos C.","family":"Siontis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Murgatroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas V.A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4652-7791","authenticated-orcid":false,"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimie","family":"Manlucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley P.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leclercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika Maria","family":"Birgersdotter-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Breitenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence M.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Wiggenhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2026.01.052_bib1","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1001\/jamacardio.2019.4534","article-title":"Mortality among referral patients with hypertrophic cardiomyopathy vs the general european population","volume":"5","author":"Lorenzini","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A validated model for sudden cardiac death risk prediction in pediatric hypertrophic cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.01.052_bib4","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.02.061","article-title":"Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies","volume":"65","author":"Maron","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jchf.2018.02.010","article-title":"Hypertrophic cardiomyopathy: clinical update","volume":"6","author":"Geske","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacep.2026.01.052_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacep.2026.01.052_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008123","article-title":"Long-term outcome in high-risk patients with hypertrophic cardiomyopathy after primary prevention defibrillator implants","volume":"13","author":"Rowin","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pcad.2023.08.005","article-title":"Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: current state, unknowns, and future directions","volume":"80","author":"Siontis","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacep.2026.01.052_bib9","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1093\/eurheartj\/ehac496","article-title":"Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial","volume":"43","author":"Knops","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2026.01.052_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacep.2020.03.015","article-title":"Evidence that subcutaneous implantable cardioverter-defibrillators are effective and reliable in hypertrophic cardiomyopathy","volume":"6","author":"Maron","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad270","article-title":"Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator","volume":"25","author":"Francia","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2026.01.052_bib12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.hrthm.2020.02.008","article-title":"Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: an international multicenter study","volume":"17","author":"Nazer","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.01.052_bib13","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.hrthm.2016.01.001","article-title":"Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts","volume":"13","author":"Lambiase","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.01.052_bib14","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jacep.2020.05.029","article-title":"First-in-human chronic implant experience of the substernal extravascular implantable cardioverter-defibrillator","volume":"6","author":"Crozier","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacep.2026.01.052_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.124.071795","article-title":"Performance and safety of the extravascular implantable cardioverter-defibrillator through long-term follow-up: final results from the Pivotal Study","volume":"151","author":"Friedman","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2026.01.052_bib17","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/jce.15190","article-title":"The extravascular implantable cardioverter-defibrillator: the Pivotal Study plan","volume":"32","author":"Crozier","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib18","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib19","first-page":"176","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"69","author":"Priori","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacep.2026.01.052_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jce.16150","article-title":"The clinical and economic impact of extended battery longevity of a substernal extravascular implantable cardioverter defibrillator","volume":"35","author":"Knight","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacep.2019.05.026","article-title":"Cardiovascular implantable electronic device infection: procedure versus lifetime risk","volume":"5","author":"Tarakji","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCEP.113.001217","article-title":"Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis","volume":"7","author":"Tan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.124.013479","article-title":"Global and temporal trends in utilization and outcomes of implantable cardioverter defibrillators in hypertrophic cardiomyopathy","volume":"18","author":"Abdelfattah","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.jacep.2024.02.033","article-title":"Extravascular implantable cardioverter-defibrillator sensing and detection in a large global population","volume":"10","author":"Swerdlow","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.13194","article-title":"Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: triggers, treatment, and implications","volume":"28","author":"Link","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jce.16151","article-title":"Patient-reported quality of life and acceptance of the extravascular implantable cardioverter-defibrillator: results from pivotal study","volume":"35","author":"Sears","year":"2024","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacep.2026.01.052_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.hroo.2024.09.022","article-title":"Design of a post-market registry for the extravascular implantable cardioverter-defibrillator: the Enlighten study","volume":"6","author":"Boersma","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacep.2026.01.052_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.hrthm.2025.02.012","article-title":"Periprocedural outcomes from the postmarket study of the extravascular implantable cardioverter-defibrillator: preliminary Enlighten study results and meta-analysis","volume":"23","author":"Crozier","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2026.01.052_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae225","article-title":"Comprehensive analysis of substernal lead removal: experience from EV-ICD Pilot, Pivotal, and Continued Access studies","volume":"26","author":"Sagi","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2026.01.052_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jce.16530","article-title":"Uncomplicated extravascular implantable cardioverter-defibrillator extraction after 4 years dwell time: a case report","volume":"36","author":"de Veld","year":"2025","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X26001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:34:14Z","timestamp":1785339254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X26001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2405500X26001271"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2026.01.052","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance and Safety of the Extravascular Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2026.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}